Orthofix Medical Inc. (OFIX) stock
OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3049% below fair value
$7.17+0.23 (+3.31%)
Close on Nov 13, 2026Market cap $292.05MP/E –Yield –
Orthofix Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Orthofix Medical's profit margin for the twelve months ending Sep 30, 2026 was -5.4%. For fiscal 2025 it was -11.2%, against -15.8% the year before. The highest annual figure on record is 9.7% in fiscal 2012.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -11.2% | +4.5 |
| FY2024 | Dec 31, 2024 | -15.8% | +4.5 |
| FY2023 | Dec 31, 2023 | -20.3% | −16.0 |
| FY2022 | Dec 31, 2022 | -4.3% | +4.0 |
| FY2021 | Dec 31, 2021 | -8.3% | −8.9 |
| FY2020 | Dec 31, 2020 | 0.6% | +6.8 |
| FY2019 | Dec 31, 2019 | -6.2% | −9.2 |
| FY2018 | Dec 31, 2018 | 3.0% | +1.6 |
| FY2017 | Dec 31, 2017 | 1.4% | +0.7 |
| FY2016 | Dec 31, 2016 | 0.7% | +1.5 |
| FY2015 | Dec 31, 2015 | -0.7% | +1.4 |
| FY2014 | Dec 31, 2014 | -2.1% | +5.1 |
| FY2013 | Dec 31, 2013 | -7.2% | −17.0 |
| FY2012 | Dec 31, 2012 | 9.7% | +13.8 |
| FY2011 | Dec 31, 2011 | -4.1% | −13.6 |
| FY2010 | Dec 31, 2010 | 9.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -2.9% | +8.2 |
| Q2 FY2026 | Jun 30, 2026 | -7.5% | −0.6 |
| Q1 FY2026 | Mar 31, 2026 | -10.6% | +16.8 |
| Q4 FY2025 | Dec 31, 2025 | -1.0% | +12.5 |
| Q3 FY2025 | Sep 30, 2025 | -11.1% | +2.8 |
| Q2 FY2025 | Jun 30, 2025 | -6.9% | +9.9 |
| Q1 FY2025 | Mar 31, 2025 | -27.4% | −8.3 |
| Q4 FY2024 | Dec 31, 2024 | -13.5% | −2.5 |
| Q3 FY2024 | Sep 30, 2024 | -13.9% | +1.8 |
| Q2 FY2024 | Jun 30, 2024 | -16.8% | +4.2 |
| Q1 FY2024 | Mar 31, 2024 | -19.1% | +15.7 |
| Q4 FY2023 | Dec 31, 2023 | -11.1% | −5.3 |
| Q3 FY2023 | Sep 30, 2023 | -15.7% | −6.3 |
| Q2 FY2023 | Jun 30, 2023 | -21.1% | −23.2 |
| Q1 FY2023 | Mar 31, 2023 | -34.8% | −30.6 |
| Q4 FY2022 | Dec 31, 2022 | -5.8% | +20.5 |
| Q3 FY2022 | Sep 30, 2022 | -9.4% | −7.5 |
| Q2 FY2022 | Jun 30, 2022 | 2.1% | +0.1 |
| Q1 FY2022 | Mar 31, 2022 | -4.2% | +1.3 |
| Q4 FY2021 | Dec 31, 2021 | -26.2% | −18.3 |
| Q3 FY2021 | Sep 30, 2021 | -1.9% | −6.1 |
| Q2 FY2021 | Jun 30, 2021 | 2.0% | +27.2 |
| Q1 FY2021 | Mar 31, 2021 | -5.5% | −30.0 |
| Q4 FY2020 | Dec 31, 2020 | -8.0% | −17.6 |
| Q3 FY2020 | Sep 30, 2020 | 4.2% | +39.9 |
| Q2 FY2020 | Jun 30, 2020 | -25.2% | −24.7 |
| Q1 FY2020 | Mar 31, 2020 | 24.5% | +23.7 |
| Q4 FY2019 | Dec 31, 2019 | 9.6% | +2.3 |
| Q3 FY2019 | Sep 30, 2019 | -35.7% | −34.6 |
| Q2 FY2019 | Jun 30, 2019 | -0.5% | −1.3 |
| Q1 FY2019 | Mar 31, 2019 | 0.8% | −4.0 |
| Q4 FY2018 | Dec 31, 2018 | 7.3% | +6.0 |
| Q3 FY2018 | Sep 30, 2018 | -1.1% | −4.4 |
| Q2 FY2018 | Jun 30, 2018 | 0.8% | −2.7 |
| Q1 FY2018 | Mar 31, 2018 | 4.8% | +7.4 |
| Q4 FY2017 | Dec 31, 2017 | 1.3% | +4.3 |
| Q3 FY2017 | Sep 30, 2017 | 3.3% | – |
| Q2 FY2017 | Jun 30, 2017 | 3.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -2.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -3.0% | – |
See a number that looks wrong?